THANHTHAO LE: Open Payments
NPI 1851999106 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,323 in 67 payments from 17 companies in 2025. Trend: 2023 $1,257 · 2024 $785 · 2025 $1,323
Food & beverage: $1,224Education: $99
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $265 |
| Janssen Biotech, Inc. | 9 | $247 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $149 |
| ABBVIE INC. | 5 | $102 |
| Ardelyx, Inc. | 3 | $94 |
| Madrigal Pharmaceuticals | 4 | $90 |
| Phathom Pharmaceuticals, Inc. | 7 | $87 |
| GENZYME CORPORATION | 2 | $56 |
| Ipsen Biopharmaceuticals, Inc | 2 | $45 |
| Lilly USA, LLC | 2 | $35 |
Products named: TREMFYA, ENTYVIO, XIFAXAN, IBSRELA, REZDIFFRA, VOQUEZNA, DUPIXENT, IQIRVO.
Industry payments across MD — which companies pay providers there.
